Dicerna Announces Second Quarter 2015 Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Dicerna Pharma (DRNA) Misses Q2 EPS by 7c
August 6, 2015 4:12 PM EDTDicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($0.85), $0.07 worse than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
... More